Tesamorelin Peptide – 10 mg Lyophilized Research Peptide (RUO)

Tesamorelin is a synthetic peptide engineered as a growth hormone–releasing hormone (GHRH) analog. In research environments, this peptide is commonly utilized for biochemical, endocrine, and molecular signaling investigations.

This Tesamorelin research peptide is provided as a high-purity lyophilized powder, supporting stability and consistency in controlled laboratory applications. The product is manufactured and distributed exclusively for scientific research purposes and is not intended for clinical, diagnostic, therapeutic, or consumer use.

All handling and experimentation involving this peptide should be conducted by qualified professionals following applicable laws, institutional protocols, and safety standards.

Research Use Only (RUO) & Compliance Notice

• For laboratory research purposes only
• Not for human or animal use
• Not a dietary supplement
• Not FDA-approved
• Not for medical, veterinary, or household use

The purchaser assumes full responsibility for the proper storage, handling, and use of this research peptide.

Tesamorelin Peptide Research Overview (Non-Clinical)

In non-clinical, academic, and laboratory research settings, Tesamorelin has been studied as a GHRH analog peptide in areas such as:

• Growth hormone signaling pathways
• Endocrine and neuroendocrine peptide regulation
• Pituitary–hypothalamic feedback mechanisms
• Metabolic signaling research models
• Adipose tissue biology in controlled environments

Although Tesamorelin has appeared in peer-reviewed clinical research, including studies related to HIV-associated lipodystrophy, these uses are not applicable to research-grade peptide materials and fall outside the scope of this product.